nach oben

Erschienen in:

01.11.2006 | ORIGINAL COMMUNICATION

Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities

verfasst von: Antonio Giorgio, MD, Maria T. Dotti, MD, Marco Battaglini, MSc, Silvia Marino, MD, Marzia Mortilla, MD, Maria L. Stromillo, MD, Placido Bramanti, MD, Alfredo Orrico, MD, Antonio Federico, MD, Nicola De Stefano, MD

Erschienen in: Journal of Neurology | Ausgabe 11/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate, by using quantitative MRI metrics, subtle cortical changes in brains of patients with the adult form of myotonic dystrophy type I (DM1) who showed no or minimal abnormalities on MRI.

Background

DM1 is an autosomal dominant multisystem disorder caused by the expansion of CTG repeats in the myotonic dystrophy-protein kinase gene. Mild to severe involvement of the CNS can be part of the clinical features of the disease. Several MRI studies have demonstrated that both focal white matter (WM) lesions and diffuse grey matter atrophy can be found in the brains of DM1 patients. However, whether these two processes are related or may occur independently is not clear.

Design/Methods

Ten genetically-proven DM1 patients who showed no or minimal abnormalities on MRI underwent a new brain MRI examination to obtain computerized measures of total and regional brain volumes normalized to head size and regional measurements of the magnetization transfer ratio (MTr).

Results

Normalized brain volumes (NBV) were significantly (p < 0.0001) lower in DM1 subjects than in a group of age- and sex-matched normal controls. Normalized cortical volumes (NCV) also were lower (p = 0.003) in DM1 subjects than in normal controls, whereas normalized WM volumes were not different between the two groups (p = 0.3). In agreement with this, values of MTr in the neocortex (cortical-MTr) were significantly (p = 0.006) lower in DM1 patients than in normal controls and this difference was not found in the WM tissue (p = 0.8).

Conclusions

Neocortical damage seems to be evident in the absence of visible WM lesions suggesting that a neocortical pathology, unrelated to WM lesion formation, occurs in DM1 brains.

Abe K, Fujimura H, Toyooka K, Yorifuji S, Nishikawa Y, Hazama T, et al (1994) Involvement of the central nervous system in myotonic dystrophy. J Neurol Sci 20;127:179–185

Akiguchi I, Nakano S, Shiino A, Kimura R, Inubushi T, Handa J, et al (1999) Brain proton magnetic resonance spectroscopy and brain atrophy in myotonic dystrophy. Arch Neurol 56:325–330CrossRefPubMed

Antonini G, Mainero C, Romano A, Giubilei F, Ceschin V, Gragnani F, et al (2004) Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosurg.Psychiatry 75:1611–1613CrossRefPubMed

Bachmann G, Damian MS, Koch M, Schilling G, Fach B, Stoppler S (1996) The clinical and genetic correlates of MRI findings in myotonic dystrophy. Neuroradiology 38:629–635CrossRefPubMed

Bozzali M, Franceschi M, Falini A, Pontesilli S, Cercignani M, Magnani G, et al (2001) Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 57:1135–1137PubMed

Brex PA, Jenkins R, Fox NC, Crum WR, O’Riordan JI, Plant GT, et al (2000) Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 54:1689–1691PubMed

Buxton J, Shelbourne P, Davies J, Jones C, Van TT, Aslanidis C, et al (1992) Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355:547–548CrossRefPubMed

Censori B, Danni M, Del PM, Provinciali L (1990) Neuropsychological profile in myotonic dystrophy. J Neurol 237:251–256CrossRefPubMed

Censori B, Provinciali L, Danni M, Chiaramoni L, Maricotti M, Foschi N, et al (1994) Brain involvement in myotonic dystrophy: MRI features and their relationship to clinical and cognitive conditions. Acta Neurol Scand 90:211–217PubMedCrossRef

10.

Chan D, Fox NC, Jenkins R, Scahill RI, Crum WR, Rossor MN (2001) Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology 57:1756–1763PubMed

11.

Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125:327–337CrossRefPubMed

12.

De Stefano N., Matthews PM, Filippi M, Agosta F, De LM, Bartolozzi ML, et al (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157–1162PubMed

13.

Di Costanzo A, Di Salle F, Santoro L, Bonavita V, Tedeschi G (2001) T2 relaxometry of brain in myotonic dystrophy. Neuroradiology 43:198–204CrossRefPubMed

14.

Di Costanzo A, Di Salle F, Santoro L, Tessitore A, Bonavita V, Tedeschi G (2002) Pattern and significance of white matter abnormalities in myotonic dystrophy type 1: an MRI study. J Neurol 249:1175–1182CrossRefPubMed

15.

Fu YH, Pizzuti A, Fenwick RG, Jr., King J, Rajnarayan S, Dunne PW, et al (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256–1258CrossRefPubMed

16.

Glantz RH, Wright RB, Huckman MS, Garron DC, Siegel IM (1988) Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch Neurol 45:36–37PubMed

17.

Grossman RI, Gomori JM, Ramer KN, Lexa FJ, Schnall MD (1994) Magnetization transfer: theory and clinical applications in neuroradiology. RadioGraphics 14:279–290PubMed

18.

Harper PS (2002) Myotonic dystrophy. Philadelphia PA: WB Saunders

19.

Huber SJ, Kissel JT, Shuttleworth EC, Chakeres DW, Clapp LE, Brogan MA (1989) Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol 46:536–540PubMed

20.

Iannucci G, Dichgans M, Rovaris M, Bruning R, Gasser T, Giacomotti L, et al (2001) Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 32:643–648PubMed

21.

Inglese M, Destefano N, Pagani E, Dotti MT, Comi G, Federico A, et al (2003) Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging. AJNR Am.J.Neuroradiol. 24:495–500PubMed

22.

Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum.Mol.Genet 13:3079–3088CrossRefPubMed

23.

Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K, et al (2003) Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neuroscience Letters 348:73–76CrossRefPubMed

24.

Mankodi A, Thornton CA (2002) Myotonic syndromes. Curr.Opin.Neurol 15:545–552CrossRefPubMed

25.

Mathieu J, Boivin H, Meunier D, Gaudreault M, Begin P (2001) Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology 56:336–340PubMed

26.

Miaux Y, Chiras J, Eymard B, Lauriot-Prevost MC, Radvanyi H, Martin-Duverneuil N, et al (1997) Cranial MRI findings in myotonic dystrophy. Neuroradiology 39:166–170CrossRefPubMed

27.

Mizukami K, Sasaki M, Baba A, Suzuki T, Shiraishi H (1999) An autopsy case of myotonic dystrophy with mental disorders and various neuropathologic features. Psychiatry Clin Neurosci 53:51–55CrossRefPubMed

28.

Naka H, Imon Y, Ohshita T, Honjo K, Kitamura T, Mimori Y, et al (2002) Magnetization transfer measurements of cerebral white matter in patients with myotonic dystrophy. J Neurol Sci 193:111–116CrossRefPubMed

29.

O’Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, et al (2001) Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 56:1386–1388PubMed

30.

Pike GB, De Stefano N, Narayanan S, Worsley KJ, Pelletier D, Francis GS, et al (2000) Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 215:824–830PubMed

31.

Pike GB, Glover GH, Hu BS, Enzmann DR (1993) Pulsed magnetization transfer spin-echo MR imaging. J.Magn Reson.Imaging 3:531–539PubMed

32.

Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56:407–415CrossRefPubMed

33.

Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, Wattez A, et al (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum.Mol.Genet 10:2143–2155CrossRefPubMed

34.

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al (2004) Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23 (Suppl 1):S208–19 S208–S219CrossRefPubMed

35.

Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al (2002) Accurate, robust and automated longitudinal and cross-sectional brain change analysis. NeuroImage 17:479–489CrossRefPubMed

36.

Steens SC, dmiraal-Behloul F, Bosma GP, Steup-Beekman GM, Olofsen H, Le CS, et al (2004) Selective gray matter damage in neuropsychiatric lupus. ArthrRheum 50:2877–2881CrossRef

37.

Vermersch P, Sergeant N, Ruchoux MM, Hofmann-Radvanyi H, Wattez A, Petit H, et al (1996) Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 47:711–717PubMed

38.

Yoshimura N, Otake M, Igarashi K, Matsunaga M, Takebe K, Kudo H (1990) Topography of Alzheimer’s neurofibrillary change distribution in myotonic dystrophy. Clin Neuropathol 9:234–239PubMed

Titel: Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities
verfasst von: Antonio Giorgio, MD
Maria T. Dotti, MD
Marco Battaglini, MSc
Silvia Marino, MD
Marzia Mortilla, MD
Maria L. Stromillo, MD
Placido Bramanti, MD
Alfredo Orrico, MD
Antonio Federico, MD
Nicola De Stefano, MD
Publikationsdatum: 01.11.2006
Verlag: Steinkopff-Verlag
Erschienen in: Journal of Neurology / Ausgabe 11/2006
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-006-0248-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objective

Background

Design/Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2006

Ongoing treatment trials for multiple sclerosis, stroke, and mitochondrial disorders

Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men

An alternative clinical postural stability test for patients with Parkinson’s disease

Differentiating Alzheimer’s disease from subcortical vascular dementia with the FAB test

Between Wallenberg syndrome and hemimedullary lesion